Visufarma

GHO Capital closes €660 million private equity fund

London, UK – GHO Capital, the European specialist investor in healthcare, today announces the successful final close for GHO Capital Fund I LP, a €660 million private equity fund which has been raised to seize the highly attractive and underpenetrated investment opportunity in European healthcare. GHO Capital Fund I LP (“the Fund”) was significantly oversubscribed,… read more

GHO Capital announces two acquisitions to create pan-European ophthalmic specialty pharmaceutical company

London, UK – GHO Capital, the European specialist investor in healthcare, has entered into an agreement to acquire the European commercial operations of Nicox S.A. (“Nicox”) (Euronext Paris: FR0013018124, COX), the international ophthalmic company, and to acquire the entire issued share capital of Visufarma Spa (“Visufarma”), a private Italian ophthalmic company. The combined platform will… read more

Subscribe to our email alerts

Email updates